Literature DB >> 32840311

Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease.

Noel T Mueller1,2, Tiange Liu1, Elana B Mitchel3, Katherine P Yates1, Ayako Suzuki4, Cynthia Behling5, Joel E Lavine3.   

Abstract

CONTEXT: Sex hormones have been linked with presence and severity of nonalcoholic fatty liver disease (NAFLD) in adults, but it is unknown if they affect severity of pediatric NAFLD.
OBJECTIVE: To examine associations of circulating SHBG, estrogens, and androgens with key histologic features of pediatric, biopsy-confirmed NAFLD.
DESIGN: Baseline assessment of longitudinal cohorts and randomized clinical trials.
SETTING: Nonalcoholic Steatohepatitis Clinical Research Network. PATIENTS: Children and adolescents ≤18 years with liver biopsy-confirmed NAFLD in the United States. MAIN OUTCOME MEASURES: We assayed SHBG, estrone, estradiol, dehydroepiandrosterone (DHEAS), androstenedione, and testosterone in relation to grade/stage of steatosis, portal inflammation, hepatic ballooning, fibrosis, and nonalcoholic steatohepatitis (NASH) severity using linear regression.
RESULTS: Mean age of 573 children at the time of biopsy was 13.1 years (SD 2.8). Lower SHBG was inversely associated with steatosis severity in boys and girls (P = 0.001), and with portal inflammation in girls only (P for sex interaction <0.001). Higher testosterone was related to improved features of steatosis and fibrosis (P for sex interaction = 0.003 and 0.01, respectively) in boys, but detrimental in girls. In boys and girls, higher estrone, estradiol, and testosterone were associated with lower portal inflammation grade; higher estradiol was positively associated with hepatic ballooning severity; DHEAS was inversely associated with hepatic ballooning and NASH severity (all P < 0.05). Androstenedione was not associated with NAFLD features.
CONCLUSIONS: Largely consistent with findings in adults, sex hormones are associated with distinct histologic features of NAFLD in children and adolescents. These hormone levels relate to differences with gender and pubertal change. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  estrogen; histology; progesterone; puberty; sex hormone binding globulin; testosterone

Mesh:

Substances:

Year:  2020        PMID: 32840311      PMCID: PMC7494240          DOI: 10.1210/clinem/dgaa574

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  27 in total

Review 1.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

2.  A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease.

Authors:  Jagpal Singh Klair; Ju Dong Yang; Manal F Abdelmalek; Cynthia D Guy; Ryan M Gill; Katherine Yates; Aynur Unalp-Arida; Joel E Lavine; Jeanne M Clark; Anna Mae Diehl; Ayako Suzuki
Journal:  Hepatology       Date:  2016-04-05       Impact factor: 17.425

Review 3.  Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men.

Authors:  G-X Tian; Y Sun; C-J Pang; A-H Tan; Y Gao; H-Y Zhang; X-B Yang; Z-X Li; Z-N Mo
Journal:  Obes Rev       Date:  2012-01-12       Impact factor: 9.213

4.  Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis.

Authors:  Mariana Lazo; Irfan Zeb; Khurram Nasir; Russell P Tracy; Matthew J Budoff; Pamela Ouyang; Dhananjay Vaidya
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 11.382

5.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

Review 6.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

Review 7.  Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

Authors:  Zobair M Younossi; Aaron B Koenig; Dinan Abdelatif; Yousef Fazel; Linda Henry; Mark Wymer
Journal:  Hepatology       Date:  2016-02-22       Impact factor: 17.425

Review 8.  Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.

Authors:  Dana Goldner; Joel E Lavine
Journal:  Gastroenterology       Date:  2020-03-20       Impact factor: 22.682

9.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010.

Authors:  Jean A Welsh; Saul Karpen; Miriam B Vos
Journal:  J Pediatr       Date:  2012-10-17       Impact factor: 4.406

Review 10.  Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.

Authors:  Maria Grazia Clemente; Claudia Mandato; Marco Poeta; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

View more
  5 in total

Review 1.  Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome.

Authors:  Xianqin Qu; Richard Donnelly
Journal:  Int J Mol Sci       Date:  2020-11-01       Impact factor: 5.923

2.  Dietary quercetin and vitamin E supplementation modulates the reproductive performance and antioxidant capacity of aged male breeder chickens.

Authors:  Felix Kwame Amevor; Zhifu Cui; Zifan Ning; Gang Shu; Xiaxia Du; Ningning Jin; Xun Deng; Dan Xu; Yaofu Tian; Yao Zhang; Diyan Li; Yan Wang; Xiaohui Du; Xiaoling Zhao
Journal:  Poult Sci       Date:  2022-03-11       Impact factor: 4.014

3.  Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity.

Authors:  Xuelian Zhou; Xiufu Lin; Jingnan Chen; Jiaqi Pu; Wei Wu; Zhaoyuan Wu; Hu Lin; Ke Huang; Li Zhang; Yangli Dai; Yan Ni; Guanping Dong; Junfen Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

4.  Low Serum Total Testosterone Is Associated with Non-Alcoholic Fatty Liver Disease in Men but Not in Women with Type 2 Diabetes Mellitus.

Authors:  Xinxin Zhang; Jinfeng Xiao; Qi Liu; Yuanyuan Ye; Weihong Guo; Jingqiu Cui; Qing He; Wenli Feng; Ming Liu
Journal:  Int J Endocrinol       Date:  2022-08-27       Impact factor: 2.803

Review 5.  Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.

Authors:  Daisuke Tokuhara
Journal:  Front Nutr       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.